From April 1, 2024 to April 9, 2024, the company has repurchased 600,000 shares, representing 0.11% for CNY 10.48 million. With this, the company has completed the repurchase of 1,260,000 shares, representing 0.23% for CNY 29.87 million under the buyback announced on October 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.22 CNY | 0.00% |
|
-5.08% | -55.39% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-55.39% | 842M | |
+61.22% | 846B | |
+39.61% | 628B | |
-4.66% | 360B | |
+16.77% | 322B | |
+8.50% | 297B | |
+14.64% | 240B | |
+18.06% | 223B | |
+3.39% | 224B | |
+11.68% | 173B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.